Patents
Patents for C07J 21 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton (1,576)
03/2007
03/21/2007CN1934126A Process for the preparation of 9, 11 epoxy steroids
03/15/2007US20070060746 Processes for preparation of 9,11 epoxy steroids and intermediates useful therein
03/08/2007WO2007025780A2 Aldosterone receptor antagonists
03/07/2007CN1922998A Use of sapogenin compound as bactericidal agent
02/2007
02/21/2007EP1562974B1 Processes for preparing c-7 substituted 5-androstenes
02/07/2007CN1298731C Antineoplastic compound, its preparation method and medicine composition with compound as active ingredient
02/01/2007DE19535572B4 Verfahren zur Herstellung von 17 α-Fluor-steroid-ketonen Process for the preparation of 17 α-fluoro-steroid ketones
01/2007
01/31/2007CN1903872A Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds
01/17/2007CN1896093A Preparation of yam saponine by hydrolysis of supercritical water
01/11/2007WO2007004090A2 Improved processes for the preparation of purified solanesol, solanesyl bromide and solanesyl acetone
01/11/2007CA2613574A1 Improved processes for the preparation of purified solanesol, solanesyl bromide and solanesyl acetone
01/04/2007US20070004689 Antiangiogenic agents
01/02/2007CA2347346C Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds
12/2006
12/27/2006EP1525214B1 Process and new intermediates for the preparation of steroids with a progestogen activity
12/13/2006EP1730164A1 Improved process for the preparation of 9,11 epoxy steroids
12/07/2006US20060276443 21-substituted progesterone derivatives as new antiprogestational agents
12/06/2006CN1288163C Preparation process for compound of proto steroid soap oside and application thereof
11/2006
11/29/2006CN1869054A Preparation method of ginseng group saponine
11/29/2006CN1869053A Method of extracting and separating ginseng saponine mixture from American ginseng leaf
11/29/2006CN1869049A Method of extracting and separating ginseng saponine from American ginseng leaf
11/16/2006US20060258857 Process for making steroidal compounds
11/02/2006US20060247216 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
10/2006
10/31/2006US7129345 Keto-substituted steroid compounds
10/18/2006EP1274718B1 A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group
10/18/2006EP0914165B1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms
10/10/2006CA2273343C Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
09/2006
09/27/2006CN1839145A Steroid spirolactonization
09/26/2006US7112670 Crystal form
09/26/2006US7112669 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
09/21/2006US20060211857 6,7-Oxygenated steroids and uses related thereto
09/13/2006EP1534732B1 5 androsten-3-ol steroid intermediates and processes for their preparation
09/06/2006EP1303308B1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
08/2006
08/29/2006CA2212856C Benzopyran-containing compounds and method for their use
08/23/2006EP1339734B1 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes
08/23/2006CN1821263A Intermediates for 16 beta -methyl steroids
08/17/2006WO2006032970A3 PROCESS FOR PREPARING 7α-ALKOXYCARBONYL SUBSTITUTED STEROIDS
08/15/2006US7091187 Using steroid; autoimmune disease
08/08/2006US7087591 21-substituted progesterone derivatives as new antiprogestational agents
08/02/2006EP1272196B1 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha,11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use
08/01/2006CA2191397C Method for the preparation of steroid derivative ketal
07/2006
07/27/2006US20060166952 Cardenolide glycosides, which have a cytotoxic activity, cancer
07/26/2006EP1082338B1 17 beta-nitro-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/19/2006EP1082337B1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/13/2006DE102004063864A1 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate 18-methyl-19-nor-17-pregn-4-en21,17-carbolactones, and pharmaceutical compositions containing them
07/12/2006EP1679317A2 5-Androsten-3 -ol steroid intermediates and processes for fheir preparation
07/11/2006CA2090584C Steroids having a methylene lactone group at position 17, process for preparing the same and their intermediates, use of the same as drugs and pharmaceutical compositions comprising the same
06/2006
06/27/2006US7067682 6,7-Oxygenated steroids and uses related thereto
06/21/2006EP1303306B1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
06/15/2006WO2006062129A1 PROCESS FOR PRODUCING (5α,7α)-3-SPIRO-2'-(1',3'-DIOXOLAN) -24-OXOCHOLEST-22-EN-7-YL BENZOATE
05/2006
05/25/2006US20060111577 Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
05/25/2006US20060111332 Process and intermediates to prepare17beta-hydroxy-7alpha-methyl-19-nor-17alpha-pregn -5(10)-en-20-yn-3-one
05/24/2006CN1775799A C22 steroid compounds and their synthesizing method
05/11/2006US20060100185 5-Androsten-3beta-ol steroid intermediates and processes for their preparation
05/04/2006WO2006045745A1 Process for the preparation of 21-hydroxy steroids with control of the epimeric distribution at the c-21 position
05/02/2006US7038040 Process for preparation of 9, 11-epoxy steroids and intermediates useful therein
04/2006
04/19/2006CN1252081C Intermediate for preparation of 16 Beta-methyl steroids
04/18/2006CA2150738C Process for preparing a 16.beta.-methyl steroid and new intermediates
03/2006
03/30/2006WO2006032970A2 PROCESS FOR PREPARING 7α-ALKOXYCARBONYL SUBSTITUTED STEROIDS
03/30/2006CA2579954A1 Process for preparing 7.alpha.-alkoxycarbonyl substituted steroids
03/29/2006CN1753905A Method of obtaining 17alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione
03/28/2006US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides
03/21/2006US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal
03/21/2006CA2124932C Sex steroid activity inhibitors
03/16/2006US20060058274 Use of an aldosterone receptor antagonist to improve cognitive function
02/2006
02/23/2006US20060040331 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
02/21/2006US7002028 fungal method for 7 beta - and 11 alpha -hydroxylation of 5-androsten-3 beta -ol-17-one to yield 5-androsten-3 beta, 7 beta, 11 alpha-triol-17-one; pharmaceuticals
01/2006
01/25/2006CN1724557A Preparation method of 9 alpha, 11 alpha-epoxy-17 beta-hydroxy-3-oxy-17 alpha pregn-4-olefine-7 alpha, 21-diformic acid gammalactone 7-methyl ester
01/18/2006EP1615944A2 Antiandrogens with marginal agonist activity and methods of use
01/11/2006EP1613640A2 Method for preparing 17 alpha-acetoxy-11 beta-(4-n,n-dimethylamin ophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
01/03/2006US6982329 provides synthetic methodology that may be employed to prepare steroid compounds having specified chemical functionality; steroids containing cyclohexene moiety are oxidized to corresponding alpha , beta -unsaturated ketone
12/2005
12/21/2005EP1606306A2 Steroid spirolactonization
12/08/2005US20050272927 Process for the preparation of 9, 11 epoxy steroids
12/01/2005US20050267302 Eplerenone crystalline form exhibiting enhanced dissolution rate
11/2005
11/17/2005US20050256094 especially those of the 20-spiroxane series; 11,12-epoxy steroid, 4,5-9,11-diepoxy steroid and 12-keto intermediates; Pregn-4-ene-7,21-dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-,?-lactone, methyl ester, (7a,11a,17a)-; eplerenone or epoxymexrenone; minimum of isolation steps
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/09/2005CN1694897A Processes for preparing 7-carboxy substituted steroids
11/09/2005CN1694896A Processes for preparing C-7 substituted 5-androstenes
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
10/2005
10/27/2005US20050239761 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
10/20/2005US20050234251 Process and new intermediates for the preparation of steroids with a progestogen activity
10/19/2005EP1586579A1 Process for the preparation of delta(15-16)-17-ketosteroids and use thereof in the synthesis of pharmacologically active compounds
10/12/2005EP1313485B1 Use of an aldosterone receptor antagonist to improve cognitive function
10/11/2005US6953851 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
10/06/2005WO2005092913A1 Improved process for the preparation of 9,11 epoxy steroids
10/06/2005CA2560389A1 Improved process for the preparation of 9,11 epoxy steroids
09/2005
09/29/2005US20050215537 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
09/27/2005US6949533 use in treating asthma, allergy, arthritis and thrombosis
09/01/2005US20050192259 A sustained release formulation of an aldosterone antagonist orally administered about 6-12 hours prior to the acrophase to provide a profile of plasma drug concentration corresponding to the diurnal cycle of plasma aldosterone concentration; hypotensive agents; circadi rhythm; cardiovascular disorders
09/01/2005CA2761534A1 A process for the preparation of drospirenone
08/2005
08/31/2005EP1335928B1 Selective glucocorticoid receptor agonists
08/25/2005US20050187202 Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols
08/23/2005US6933383 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone.
08/17/2005EP1562975A2 Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
08/17/2005EP1562974A1 Processes for preparing c-7 substituted 5-androstenes
08/10/2005EP1560841A1 Processes for preparing 7-carboxy substituted steroids
08/10/2005CN1653081A C-17 spirolactonization and 6, 7 oxidation of steroids
08/03/2005CN1650169A Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
07/2005
07/27/2005EP1556407A2 Process and intermediates to prepare 17.beta.-hydroxy-7.alfa.-methyl-19-nor-17.alfa.-pregn-5(10)-en-20-yn-3-one
07/21/2005US20050159594 Aldosterone receptor antagonist; comprises 7-methyl hydrogen 4a,5a;9a,11a-diepoxy-17 hydroxy-3-oxo-17a-pregnane-7a,21-dicarboxylate, gamma-lactone as dopant
07/20/2005EP1242444B1 Process for preparing 17alpha-acetoxy-11beta- 4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 16